I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 14 studies | 39% ± 17% | |
| endothelial cell | 7 studies | 27% ± 9% | |
| regulatory T cell | 6 studies | 19% ± 2% | |
| GABAergic neuron | 6 studies | 41% ± 20% | |
| astrocyte | 6 studies | 32% ± 14% | |
| glutamatergic neuron | 5 studies | 52% ± 26% | |
| interneuron | 5 studies | 39% ± 24% | |
| microglial cell | 5 studies | 22% ± 5% | |
| oligodendrocyte precursor cell | 5 studies | 28% ± 11% | |
| CD8-positive, alpha-beta T cell | 5 studies | 18% ± 2% | |
| plasmablast | 4 studies | 41% ± 17% | |
| CD4-positive, alpha-beta T cell | 4 studies | 21% ± 1% | |
| neuron | 4 studies | 32% ± 14% | |
| erythroblast | 4 studies | 30% ± 12% | |
| epithelial cell | 4 studies | 36% ± 7% | |
| ciliated cell | 4 studies | 23% ± 5% | |
| fibroblast | 4 studies | 19% ± 1% | |
| natural killer cell | 4 studies | 18% ± 2% | |
| endothelial cell of lymphatic vessel | 4 studies | 17% ± 2% | |
| macrophage | 4 studies | 20% ± 4% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 4% | |
| B cell | 3 studies | 18% ± 1% | |
| mast cell | 3 studies | 25% ± 7% | |
| erythrocyte | 3 studies | 33% ± 13% | |
| basal cell | 3 studies | 31% ± 5% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 4% | |
| T cell | 3 studies | 18% ± 2% |
